Major Uses

Latanoprost is most commonly used for the treatment of primary glaucoma in dogs. Latanoprost is used to supplement other topical agents when other anti-glaucoma agents have not been effective. Latanoprost works by decreasing the pressure in the eye by increasing the amount of fluid that flows out of the eye through the uveoscleral pathway.

Common Precautions

Side effects most commonly associated with latanoprost are eye irritation and excessive constriction of the pupil, tearing, and eye redness.

Latanoprost should not be administered in animals with a known allergy or hypersensitivity to the drug. Latanoprost may interact with other medications; this should be discussed with a veterinarian. Emergency veterinary care should be sought if an animal experiences any unusual symptoms.


Unopened latanoprost should be kept refrigerated. Once opened, bottles may be stored at room temperature for up to 6 weeks.


Latanoprost is available as a 0.005% solution in a 2.5 ml bottle.

A veterinarian should be consulted in regards to administration of this medication. Dose may vary in different species, when the drug is given by a different route or concurrently with other medications, and with regards to a patient's age, breed, and health status. A veterinarian's dosing instructions and/or those printed on the medication label should be followed closely.

This information is for general reference only and should not be used for the diagnosis or treatment of any condition of your pet. It's intended as a general reference, this information may not include all possible uses, precautions, directions, reactions (including allergic), drug interactions, or withdrawal times. Always consult your local veterinarian and have your pet examined for any advice concerning the diagnosis and treatment of your pet, including which products and doses are most appropriate. Any trademarks are the property of their respective owners. VetDepot is not a pharmacy. All prescription products are dispensed by our Pharmacy Partner. Article last updated 2/2014.